A randomized, double-blind, parallel-group, placebo-controlled, multicenter, phase II clinical study of famitinib in the treatment of advanced metastatic colorectal cancer | |
Xu, Rui-Hua; Shen, Lin; Wang, Keming; Wu, Gang; Shi, Chunmei; Ding, Kefeng; Lin, Lizhu; Wang, Jinwan; Xiong, Jianping; Wu, Changping | |
2015 | |
会议名称 | JOURNAL OF CLINICAL ONCOLOGY |
会议日期 | 2015-01-20 |
收录类别 | CPCI-S |
URL标识 | 查看原文 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6386257 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Xu, Rui-Hua,Shen, Lin,Wang, Keming,et al. A randomized, double-blind, parallel-group, placebo-controlled, multicenter, phase II clinical study of famitinib in the treatment of advanced metastatic colorectal cancer[C]. 见:JOURNAL OF CLINICAL ONCOLOGY. 2015-01-20. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论